Market Overview

Benzinga's Top #PreMarket Gainers

Share:
Related OPHT
Chardan Capital Initiates Ophthotech At Buy
Benzinga's Top Initiations
Related CLVS
Earnings Scheduled For February 25, 2015
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on Q4 2014 Results - Earnings Call Transcript (Seeking Alpha)

Ophthotech (NASDAQ: OPHT) soared 23.97% to $39.00 in the pre-market trading after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.

NewLead Holdings (NASDAQ: NEWL) shares jumped 12.82% to $2.20 after surging 209.72% on Monday.

Dendreon (NASDAQ: DNDN) shares jumped 10.28% to $2.36 in pre-market trading after the company announced the presentation of PROVENGE ProACT and IMPACT studies data.

Clovis Oncology (NASDAQ: CLVS) shares climbed 7.45% to $61.00 in the pre-market trading session after the company reported that it has received breakthrough therapy designation for CO-1686.

AstraZeneca PLC (NYSE: AZN) shares gained 1.95% to $72.02 in pre-market trading on investor call for talks with Pfizer (NYSE: PFE).

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (AZN + CLVS)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→